Moffitt Cancer Center Oncologist Elected To Mantle Cell Lymphoma Consortium Executive Committee

July 30, 2014

TAMPA, Fla. – The Lymphoma Research Foundation has elected Eduardo M. Sotomayor, M.D. to its Mantle Cell Lymphoma Consortium Executive Committee. The Mantle Cell Lymphoma Consortium is comprised of more than 100 laboratory and clinical scientists from North America and Europe.

Sotomayor, the Susan and John Sykes Endowed Chair ofHematologic Malignanciesat Moffitt Cancer Center, is also a member of the foundation’s Scientific Advisory Board, a group of 45 world-renowned lymphoma experts who help guide the foundation’s research activities by seeking innovative and promising projects to fund.

Mantle cell lymphoma is a rare but aggressive form of B-cell non-Hodgkin lymphoma. In 2003, the Lymphoma Research Foundation instituted the mantle cell lymphoma initiative. To date, the foundation has awarded more than $25 million in 50 separate research projects focused on developing better treatments and ultimately finding a cure for mantle cell lymphoma.

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in the Southeast and has been listed in U.S. News & World Report's  “Best Hospitals” for cancer since 1999. With more than 4,500 employees, Moffitt has an economic impact on Florida of nearly $1.6 billion. For more information, visit, and follow the Moffitt momentum on Facebook, Twitter and YouTube.